PHARMA GONRIEUX

Viroinval ·KBO/BCE: BE 0697.833.935

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	30-08-2025	30 d late	2025-00465498
31-12-2023	31-07-2024	30-08-2024	30 d late	2024-00426182
31-12-2022	31-07-2023	31-08-2023	31 d late	2023-00417943
31-12-2021	31-07-2022	29-08-2022	29 d late	2022-20398910
31-12-2020	31-07-2021	27-08-2021	27 d late	2021-58900291
31-12-2019	31-07-2020	26-10-2020	87 d late	2020-63400422

Metric	This company	Sector median	Position in the sector
Solvency	33.4%	17.2%	better than 69% of 873 sector peers
Net result	€152	€14k	better than 35% of 874 sector peers
Equity	€265k	€99k	better than 70% of 875 sector peers
Gross operating margin	€152k	€213k	better than 40% of 801 sector peers
Staff costs	€84k	€221k	higher than 24% of 721 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€794k
Fixed assets	21/28	€357k
Intangible fixed assets	21	€134k
Tangible fixed assets	22/27	€223k
Current assets	29/58	€438k
Stocks & contracts in progress	3	€113k
Amounts receivable within one year	40/41	€80k
Investments	50/53	€100k
Cash & bank	54/58	€144k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€794k
Equity	10/15	€265k
Contributions / capital	10/11	€19k
Reserves	13	€170k
Accumulated profits (losses)	14	€77k
Amounts payable	17/49	€529k
Amounts payable after one year	17	€240k
Amounts payable within one year	42/48	€283k
Trade debts payable within one year	44	€104k
Income statement
Gross operating margin	9900	€152k
Operating result	9901	€12k
Financial income	75	€0
Financial charges	65	€12k
Result before taxes	9903	€152
Net result for the period	9904	€152
Result to be appropriated	9905	€152

Summary